Dynamics of the most common pathogenic mtDNA variant m.3243A > G demonstrate frequency-dependency in blood and positive selection in the germline.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
28 11 2022
Historique:
received: 17 05 2022
revised: 29 06 2022
accepted: 29 06 2022
pubmed: 19 7 2022
medline: 1 12 2022
entrez: 18 7 2022
Statut: ppublish

Résumé

The A-to-G point mutation at position 3243 in the human mitochondrial genome (m.3243A > G) is the most common pathogenic mtDNA variant responsible for disease in humans. It is widely accepted that m.3243A > G levels decrease in blood with age, and an age correction representing ~ 2% annual decline is often applied to account for this change in mutation level. Here we report that recent data indicate that the dynamics of m.3243A > G are more complex and depend on the mutation level in blood in a bi-phasic way. Consequently, the traditional 2% correction, which is adequate 'on average', creates opposite predictive biases at high and low mutation levels. Unbiased age correction is needed to circumvent these drawbacks of the standard model. We propose to eliminate both biases by using an approach where age correction depends on mutation level in a biphasic way to account for the dynamics of m.3243A > G in blood. The utility of this approach was further tested in estimating germline selection of m.3243A > G. The biphasic approach permitted us to uncover patterns consistent with the possibility of positive selection for m.3243A > G. Germline selection of m.3243A > G shows an 'arching' profile by which selection is positive at intermediate mutant fractions and declines at high and low mutant fractions. We conclude that use of this biphasic approach will greatly improve the accuracy of modelling changes in mtDNA mutation frequencies in the germline and in somatic cells during aging.

Identifiants

pubmed: 35849052
pii: 6644887
doi: 10.1093/hmg/ddac149
pmc: PMC9703810
doi:

Substances chimiques

DNA, Mitochondrial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

4075-4086

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203105/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204709/Z/16/Z
Pays : United Kingdom

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Références

Nature. 1990 Dec 13;348(6302):651-3
pubmed: 2102678
Science. 2008 Feb 15;319(5865):958-62
pubmed: 18276892
Neurology. 2011 Nov 29;77(22):1965-71
pubmed: 22094475
Mitochondrion. 2007 May;7(3):230-3
pubmed: 17300999
J Neurol Sci. 1998 Nov 26;161(1):36-9
pubmed: 9879679
Hum Mol Genet. 2016 Mar 1;25(5):1031-41
pubmed: 26740552
Am J Med Genet A. 2009 Feb 15;149A(4):584-7
pubmed: 19253345
Sci Adv. 2021 Mar 17;7(12):
pubmed: 33731350
Am J Hum Genet. 2008 Aug;83(2):254-60
pubmed: 18674747
Clin Genet. 2018 Apr;93(4):925-928
pubmed: 29266179
J Med Genet. 2007 Jan;44(1):69-74
pubmed: 16950816
EMBO Mol Med. 2018 Jun;10(6):
pubmed: 29735722
Ann Clin Transl Neurol. 2018 Feb 07;5(3):333-345
pubmed: 29560378
Arch Dis Child. 2000 May;82(5):407-11
pubmed: 10799437
Mol Genet Metab. 2019 Sep - Oct;128(1-2):19-29
pubmed: 31648942
Ann Neurol. 2015 May;77(5):753-9
pubmed: 25652200
Mitochondrion. 2014 Jul;17:34-41
pubmed: 24846800
N Engl J Med. 2020 Oct 15;383(16):1556-1563
pubmed: 32786181
N Engl J Med. 2019 May 16;380(20):1971-1972
pubmed: 31091381
Eur J Neurol. 2017 Feb;24(2):255-261
pubmed: 27869334
Sci Adv. 2021 Dec 10;7(50):eabi5657
pubmed: 34878831
Trends Genet. 2000 Nov;16(11):500-5
pubmed: 11074292
J Neurol. 2014 Mar;261(3):504-10
pubmed: 24375076
Am J Hum Genet. 2008 Feb;82(2):333-43
pubmed: 18252214
Hum Reprod. 2018 Jul 1;33(7):1331-1341
pubmed: 29850888
J Paediatr Child Health. 2001 Feb;37(1):87-90
pubmed: 11168879
Mol Cell. 2019 Mar 21;73(6):1127-1137.e5
pubmed: 30772175
Hum Mol Genet. 2018 May 1;27(9):1565-1571
pubmed: 29474538
Prog Mol Biol Transl Sci. 2014;127:29-62
pubmed: 25149213
Nat Rev Dis Primers. 2016 Oct 20;2:16080
pubmed: 27775730
Nat Cancer. 2020 Oct;1(10):976-989
pubmed: 33073241
J Inherit Metab Dis. 2012 Nov;35(6):1059-69
pubmed: 22403016
Nat Genet. 2012 Nov;44(11):1282-5
pubmed: 23042113
J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):936-8
pubmed: 23355809

Auteurs

Melissa Franco (M)

Department of Biology, Northeastern University, Boston, MA 02115, USA.

Sarah J Pickett (SJ)

Wellcome Centre for Mitochondrial Research and Institute for Translational and Clinical Research, Newcastle University and Newcastle Medical School, Newcastle-upon-Tyne NE2 4HH, UK.

Zoe Fleischmann (Z)

Department of Biology, Northeastern University, Boston, MA 02115, USA.

Mark Khrapko (M)

Department of Biology, Northeastern University, Boston, MA 02115, USA.

Auden Cote-L'Heureux (A)

Department of Biology, Northeastern University, Boston, MA 02115, USA.

Dylan Aidlen (D)

Department of Biology, Northeastern University, Boston, MA 02115, USA.

David Stein (D)

Department of Biology, Northeastern University, Boston, MA 02115, USA.

Natasha Markuzon (N)

Draper Laboratories, Cambridge, MA 02139, USA.

Konstantin Popadin (K)

School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland.
Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland.
Center for Mitochondrial Functional Genomics, Institute of Living Systems, Immanuel Kant Baltic Federal University, Kaliningrad 236040, Russia.

Maxim Braverman (M)

Department of Mathematics, Northeastern University, Boston, MA 02115, USA.

Dori C Woods (DC)

Department of Biology, Northeastern University, Boston, MA 02115, USA.

Jonathan L Tilly (JL)

Department of Biology, Northeastern University, Boston, MA 02115, USA.

Doug M Turnbull (DM)

Wellcome Centre for Mitochondrial Research and Institute for Translational and Clinical Research, Newcastle University and Newcastle Medical School, Newcastle-upon-Tyne NE2 4HH, UK.

Konstantin Khrapko (K)

Department of Biology, Northeastern University, Boston, MA 02115, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH